Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Silk Road Medical

Silk Road Medical Stock Scores Relative Strength Rating Upgrade

Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level.

Investors Business Daily

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary

Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6 or PF-06760805 for the prevention of invasive GBS disease due to the vaccine serotypes in newborns and young infants by active immunization of their mothers during pregnancy. Pfizer shares traded in a…

Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating

Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating

Silk Road Medical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Benzinga's Top Ratings Upgrades, Downgrades For July 11, 2022

Recap: Silk Road Medical Q4 Earnings

Silk Road Medical (NASDAQ:SILK) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Earnings Preview For Silk Road Medical

Silk Road Medical (NASDAQ:SILK) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate that Silk Road Medical will report an earnings per share (EPS) of $-0.36.

1

Organisations

European Commission

Bank of America

B of A Securities

US Food and Drug Administration

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play